Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Merkel Cell 1

Interventions

durvalumab 2 avelumab 2 atezolizumab 2 Nivolumab 2 pembrolizumab 1 navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1 daromun 1 cemiplimab 1 advexin 1 Sampling Studies 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Merkel Cell × Sampling Studies × Clear all

NCT04705389 2021-05-18

SUMMERTIME

University Hospital, Tours

Phase NA Unknown

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡